CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Jan 24
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical…
21 Dec 23
Senhance System to be placed at a pediatric hospital in Timisoara, Romania
11 Dec 23
The goal of the current study was to compare OCM and Omeza Skin Protectant's antibacterial and wound-healing properties…
05 Dec 23
The SofPulse brand business is engaged in developing noninvasive wearable electroceuticals therapeutic products for pain relief, general wellness,…
22 Nov 23
This revolutionary proprietary technology, 100% biobased and meticulously designed, marks a significant advancement in textile innovation
31 Oct 23
Through the acquisition, United Therapeutics plans to expand its existing complementary platform of organ manufacturing programmes, including ex-vivo…
09 Oct 23
This Grant will Fund the Company’s Translational Research Activities Through the Completion of a Pilot Clinical Trial
16 Aug 23
Medela’s new sterile dressing solution Invia Integrated Dressing, backed by the company’s decades of expertise, extends its full-system…
09 Aug 23
The exclusive agreement follows an extensive product evaluation assessment with the goal of introducing ActiGraft to hospitals and…
27 Jul 23
The US-based clinical-stage company has designed the biomaterial to address the limitations of current embolic solutions for indications…